Neha Krishnamohan Kinnate Biopharma Inc. (KNTE) insider trading activity

Neha Krishnamohan is CHIEF FINANCIAL OFFICER of Kinnate Biopharma Inc.. Currently has a direct ownership of 0 shares of KNTE, which is worth approximately $0. The most recent transaction as insider was on Apr 03, 2024, when has been sold 64,087 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Neha Krishnamohan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 03 2024	SELL Sale (or disposition) back to the issuer	-	64,087 Reduced 100.0%	0 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$3,900 $2.59 p/Share	1,506 Reduced 2.3%	64,087 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$3,282 $2.25 p/Share	1,459 Reduced 2.18%	65,593 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$3,428 $2.35 p/Share	1,459 Reduced 2.13%	67,052 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$6,273 $4.3 p/Share	1,459 Reduced 2.09%	68,511 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$8,966 $5.21 p/Share	1,721 Reduced 2.49%	67,378 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$11,307 $7.75 p/Share	1,459 Reduced 2.07%	69,099 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	67,500 Added 49.45%	69,015 Common Stock

Also insider at

ARQT

Arcutis Biotherapeutics, Inc. Healthcare

Director

RTVA

Artiva Biotherapeutics, Inc.

Chief Financial Officer